Trade Orgenesis Inc. - ORGS CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.48 |
Open | 0.48 |
1-Year Change | -55.96% |
Day's Range | 0.48 - 0.49 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 25, 2024 | 0.49 | 0.01 | 2.08% | 0.48 | 0.49 | 0.48 |
Apr 24, 2024 | 0.48 | 0.00 | 0.00% | 0.48 | 0.49 | 0.48 |
Apr 23, 2024 | 0.48 | 0.00 | 0.00% | 0.48 | 0.49 | 0.48 |
Apr 22, 2024 | 0.48 | 0.00 | 0.00% | 0.48 | 0.48 | 0.48 |
Apr 19, 2024 | 0.48 | -0.02 | -4.00% | 0.50 | 0.50 | 0.46 |
Apr 18, 2024 | 0.48 | 0.00 | 0.00% | 0.48 | 0.49 | 0.48 |
Apr 17, 2024 | 0.48 | 0.02 | 4.35% | 0.46 | 0.49 | 0.46 |
Apr 16, 2024 | 0.48 | 0.02 | 4.35% | 0.46 | 0.52 | 0.46 |
Apr 15, 2024 | 0.47 | 0.01 | 2.17% | 0.46 | 0.47 | 0.45 |
Apr 12, 2024 | 0.47 | -0.06 | -11.32% | 0.53 | 0.53 | 0.47 |
Apr 11, 2024 | 0.52 | -0.01 | -1.89% | 0.53 | 0.59 | 0.51 |
Apr 10, 2024 | 0.54 | 0.00 | 0.00% | 0.54 | 0.85 | 0.48 |
Apr 9, 2024 | 0.47 | 0.02 | 4.44% | 0.45 | 0.47 | 0.45 |
Apr 8, 2024 | 0.44 | -0.04 | -8.33% | 0.48 | 0.48 | 0.44 |
Apr 5, 2024 | 0.49 | -0.06 | -10.91% | 0.55 | 0.55 | 0.49 |
Apr 4, 2024 | 0.55 | 0.05 | 10.00% | 0.50 | 0.55 | 0.47 |
Apr 3, 2024 | 0.46 | 0.08 | 21.05% | 0.38 | 0.47 | 0.38 |
Apr 2, 2024 | 0.40 | -0.08 | -16.67% | 0.48 | 0.48 | 0.39 |
Apr 1, 2024 | 0.55 | -0.17 | -23.61% | 0.72 | 0.72 | 0.49 |
Mar 28, 2024 | 0.80 | -0.02 | -2.44% | 0.82 | 0.82 | 0.80 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Orgenesis Inc. Company profile
About Orgenesis Inc
Orgenesis Inc. is a biotech company operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous (using the patient’s own cells) therapies with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment. The Company has developed a Point of Care Platform comprised of three components: POCare Therapies, POCare Technologies and POCare Network. Its therapeutic portfolio pipeline is diverse and addresses various clinical needs. POCare Technology uses automated systems across a collaborative POCare Network via a combination of science, technology, engineering and networking.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Orgenesis Inc revenues increased from $5.4M to $28.6M. Net loss before extraordinary items decreased 70% to $13M. Revenues reflect POC Services segment increase from $4.3M to $17.1M, Cell process development services segment increase from $1.1M to $11.5M. Lower net loss reflects Other research and development expenses decrease of 43% to $5.6M (expense).
Equity composition
Common Stock $.001 Par, 4/13, 1.75B auth., 49,617,903 issd. Insider owns approx.50.56% Effective August 31, 2011 effected a 35 to one forward stock split
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20271 Goldenrod Lane
GERMANTOWN
MARYLAND 20876
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com